Novo Nordisk

Company ● Covered in 1 story + Follow ✴ AI Graph

This profile is built automatically from TLDRocket coverage.

Signals

1 story (new)

Media momentum

As of 21 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.

1 source

Source diversity

As of 21 Sep 2026 · Distinct publications behind this entity's visible coverage.

—

Release activity

As of 21 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.

—

Funding signals

As of 21 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.

Sep 2026

Coverage span

As of 21 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.

updated 21 Sep 2026

Anonymous President & CEO
Tania Sabroe Executive Vice President, People, Organisation & Corporate Affairs
Yiannis Mallis Senior Vice President Portfolio Strategy & Access
Jamey Millar Executive Vice President, US Operations
Hong Chow Executive Vice President, Product & Portfolio Strategy
Anja Jørgensen Vice President - Head of the Corporate Ombudsman Function
Martin Holst Lange Executive Vice President of R&D & Chief Scientific Officer
Alan Moses Senior Vice President And Global Chief Medical Officer
Doug Langa Executive Vice President & Senior VP, Head of North America Operations and President of NNI
Karsten Munk Knudsen Executive Vice President, Chief Financial Officer
Steven Benz Corporate Vice President, General Counsel, Novo Nordisk Inc., US Operations
Kasper Bødker Mejlvang Executive Vice President, CMC & Product Supply

+ 18 more tracked

Month Quarter Year